Mindfulness-Based Cognitive Therapy to Prevent Relapse in Recurrent Depression

Journal of Consulting and Clinical Psychology

Volumn 76, Issue 6, 2008, Pages 966-978

  Kuyken, Willem ^a   Byford, Sarah ^b   Taylor, Rod S ^c   Watkins, Ed ^a   Holden, Emily ^a   White, Kat ^a   Barrett, Barbara ^b   Byng, Richard ^c   Evans, Alison ^d   Mullan, Eugene ^a   Teasdale, John D ^e  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

^d Devon Primary Care Trust   (United Kingdom)

^e Cambridge ESOL   (United Kingdom)

Author keywords

antidepressants; depression; health economics; mindfulness based cognitive therapy; randomized controlled trial

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINDFULNESS BASED COGNITIVE THERAPY; PROPHYLAXIS; QUALITY OF LIFE; RECURRENT DISEASE; RELAPSE; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; AWARENESS; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RECURRENCE; YOUNG ADULT;

EID: 55949116850     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0013786     Document Type: Article

References (58)

1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed. (1994), Author, Washington, DC
2. Baer R.A. Mindfulness training as a clinical intervention: A conceptual and empirical review. Clinical Psychology: Science and Practice 10 (2003) 125-143
3. Baldwin S.A., Murray D.M., and Shadish W.R. Empirically supported treatments or Type I errors? Problems with the analysis of data from group-administered treatments. Journal of Consulting and Clinical Psychology 73 (2005) 924-935
4. Barrett B., Byford S., and Knapp M. Evidence of cost-effective treatments for depression: A systematic review. Journal of Affective Disorders 84 (2005) 1-13
5. Beck A.T., Rush A.J., Shaw B.F., and Emery G. Cognitive therapy of depression (1979), Guilford Press, New York
6. Beck A.T., Steer R.A., and Brown G.K. The Beck Depression Inventory: Second Edition (1996), Psychological Corporation, San Antonio, TX
7. Bockting C.L.H., Schene A.H., Spinhoven P., Koeter M.W.J., Wouters L.F., Huyser J., et al. Preventing relapse/recurrence in recurrent depression with cognitive therapy: A randomized controlled trial. Journal of Consulting and Clinical Psychology 73 (2005) 647-657
8. Bower P., Byford S., Sibbald B., Ward E., King M., Lloyd R., et al. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression: II. Cost effectiveness. British Medical Journal 321 (2000) 1389-1392
9. British Medical Association & Royal Pharmaceutical Society of Great Britain . British national formulary 48 (2006), British Medical Journal Books/Pharmaceutical Press, London
10. Byford S., Knapp M., Greenshields J., Ukoumunne O.C., Jones V., Thompson S., et al. Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: A decision-making approach. Psychological Medicine 33 (2003) 977-986
11. Claxton K. The irrelevance of inference: A decision-making approach to the stochastic evaluation of health care technologies. Journal of Health Economics 18 (1999) 341-364
12. Coelho H.F., Canter P.H., and Ernst E. Mindfulness-based cognitive therapy: Evaluating current evidence and informing future research. Journal of Consulting and Clinical Psychology 75 (2007) 1000-1005
13. Cooper C., Bebbington P., King M., Brugha T., Meltzer H., Bhugra D., et al. Why people do not take their psychotropic drugs as prescribed: Results of the 2000 National Psychiatric Morbidity Survey. Acta Psychiatrica Scandinavica 116 (2007) 47-53
14. Curtis L., and Netten A. Unit costs of health and social care (2006), Personal Social Services Research Unit, Canterbury, England
15. Department of Health . National health service reference costs (2006), Author, London
16. Dimidjian S., Hollon S.D., Dobson K.S., Schmaling K.B., Kohlenberg R.J., Addis M.E., et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology 74 (2006) 658-670
17. Efron B., and Tibshirani R.J. An introduction to the bootstrap (1993), Chapman & Hall, New York
18. Fava G.A., Rafanelli C., Grandi S., Canestrari R., and Morphy M.A. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. American Journal of Psychiatry 155 (1998) 1443-1445
19. Fenwick E., Claxton K., and Sculpher M. Representing uncertainty: The role of cost-effectiveness acceptability curves. Health Economics 10 (2001) 779-787
20. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I disorder with psychotic screen (1995), New York Psychiatric Institute, New York
21. Frank E., Kupfer D.J., Perel J.M., Cornes C., Jarrett D.B., Mallinger A.G., et al. 3-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry 47 (1990) 1093-1099
22. Geddes J.R., Carney S.M., Davies C., Furukawa T.A., Kupfer D.J., Frank E., et al. Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review. Lancet 361 (2003) 653-661
23. Harper A., and Power M. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine 28 (1998) 551-558
24. Hirschfield R.M.A., Keller M.B., Panico S., Arons B.S., Barlow D., Davidoff F., et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. Journal of the American Medical Association 277 (1997) 333-340
25. Hollon S.D., DeRubeis R.J., Shelton R.C., Amsterdam J.D., Salomon R.M., O'Reardon J.P., et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Archives of General Psychiatry 62 (2005) 417-422
26. Hollon S.D., Munoz R.F., Barlow D.H., Beardslee W.R., Bell C.C., Bernal G., et al. Psychosocial intervention development for the prevention and treatment of depression: Promoting innovation and increasing access. Biological Psychiatry 52 (2002) 610-630
27. Judd L.L. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey: Discussion. Journal of Affective Disorders 45 (1997) 28-29
28. Judd L.L. The clinical course of unipolar major depressive disorders. Archives of General Psychiatry 54 (1997) 989-991
29. Judd L.L., Paulus M.P., Zeller P., Fava G.A., Rafanelli C., Grandi S., et al. The role of residual subthreshold depressive symptoms in early episode relapse in unipolar major depressive disorder. Archives of General Psychiatry 56 (1999) 764-765
30. Kabat-Zinn J. Full catastrophe living: How to cope with stress, pain and illness using mindfulness meditation (1990), Delacorte, New York
31. Katon W., Rutter C., Ludman E.J., Von Korff M., Lin E., Simon G., et al. A randomized trial of relapse prevention of depression in primary care. Archives of General Psychiatry 58 (2001) 241-247
32. Katon W., and Schulberg H. Epidemiology of depression in primary care. General Hospital Psychiatry 14 (1992) 237-247
33. Keller M.B., Klerman G.L., Lavori P.W., Coryell W., Endicott J., and Taylor J. Long-term outcome of episodes of major depression: Clinical and public-health significance. Journal of the American Medical Association 252 (1984) 788-792
34. Koopmanschap M.A., and Rutten F.F.H. A practical guide for calculating indirect costs of disease. Pharmacoeconomics 10 (1996) 460-466
35. Kupfer D.J., Frank E., Perel J.M., Cornes C., Mallinger A.G., Thase M.E., et al. 5-year outcome for maintenance therapies in recurrent depression. Archives of General Psychiatry 49 (1992) 769-773
36. Kuyken W., Orley J., Power M., Herrman H., Schofield H., Murphy B., et al. The World Health Organization Quality of Life Assessment (WHOQOL): Position paper from the World Health Organization. Social Science & Medicine 41 (1995) 1403-1409
37. Lau M.A., Segal Z.V., and Williams J.M. Teasdale's differential activation hypothesis: Implications for mechanisms of depressive relapse and suicidal behaviour. Behaviour Research and Therapy 42 (2004) 1001-1017
38. Laurenceau J.P., Hayes A.M., and Feldman G.C. Some methodological and statistical issues in the study of change processes in psychotherapy. Clinical Psychology Review 27 (2007) 682-695
39. Liu C.F., Hedrick S.C., Caheny E.F., Heagerty P., Felker B., Hasenberg N., et al. Cost-effectiveness of collaborative care for depression in a primary care veteran population. Psychiatric Services 54 (2003) 698-704
40. Ma S.H., and Teasdale J.D. Mindfulness-based cognitive therapy for depression: Replication and exploration of differential relapse prevention effects. Journal of Consulting and Clinical Psychology 72 (2004) 31-40
41. Morisky D.E., Green L.W., and Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care 24 (1986) 67-74
42. National Institute for Clinical Excellence . Depression: Management of depression in primary and secondary care (Clinical Guideline No. 23) (2004). http://www.nice.org.uk/CG023NICEguideline www.nice.org.uk/CG023NICEguideline
43. Olfson M., Marcus S.C., Tedeschi M., and Wan G.J. Continuity of antidepressant treatment for adults with depression in the United States. American Journal of Psychiatry 163 (2006) 101-108
44. Paykel E.S., Scott J., Teasdale J.D., Johnson A.L., Garland A., Moore R., et al. Prevention of relapse in residual depression by cognitive therapy: A controlled trial. Archives of General Psychiatry 56 (1999) 829-835
45. Prien R.F., and Kupfer D.J. Continuation drug therapy for major depressive episodes: How long should it be maintained?. American Journal of Psychiatry 143 (1986) 18-23
46. Segal Z.V., Teasdale J.D., Williams J.M., and Gemar M.C. The Mindfulness-Based Cognitive Therapy Adherence Scale: Inter-rater reliability, adherence to protocol and treatment distinctiveness. Clinical Psychology & Psychotherapy 9 (2002) 131-138
47. Segal Z.V., Williams J.M.G., and Teasdale J.D. Mindfulness-based cognitive therapy for depression: A new approach to preventing relapse (2002), Guilford Press, New York
48. Simon G.E., Katon W.J., Von Korff M., Unutzer J., Lin E.H.B., Walker E.A., et al. Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. American Journal of Psychiatry 158 (2001) 1638-1644
49. Simon G.E., Von Korff M., Ludman E.J., Katon W.J., Rutter C., Unutzer J., et al. Cost-effectiveness of a program to prevent depression relapse in primary care. Medical Care 40 (2002) 941-950
50. Teasdale J.D., Segal Z.V., Williams J.M.G., Ridgeway V.A., Soulsby J.M., and Lau M.A. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology 68 (2000) 615-623
51. Thompson S.G., and Barber J.A. How should cost data in pragmatic randomised trials be analysed?. British Medical Journal 320 (2000) 1197-1200
52. Vanhout B.A., Al M.J., Gordon G.S., and Ruten F.F.H. Costs, effects and C/E ratios alongside a clinical trial. Health Economics 3 (1994) 309-319
53. van Schaik D.J.F., Klein A.F.J., van Hout H.P.J., van Marwijk H.W.J., Beekman A.T.F., de Haan M., et al. Patients' preferences in the treatment of depressive disorder in primary care. Psychiatry and Primary Care 26 (2004) 184-189
54. White K., Holden E.R., Byng R., Mullan E., and Kuyken W. Under/over-recruitment to mental health trials. Acta Psychiatrica Scandinavica 116 (2007) 158
55. Williams J.B. A structured interview guide for the Hamilton Depression Rating Scale. Archives of General Psychiatry 45 (1988) 742-747
56. Williams J.M.G., Teasdale J.D., Segal Z.V., and Kabat-Zinn J. The mindful way through depression: Freeing yourself from chronic unhappiness (2007), Guilford Press, New York
57. World Health Organization . The World Health Organization Quality of Life (WHOQOL)-BREF [Questionnaire] (2004). http://www.who.int/substance_abuse/research_tools/en/english_whoqol.pdf Retrieved May 7, 2008, from http://www.who.int/substance_abuse/research_tools/en/english_whoqol.pdf
58. Zimmerman M., McGlinchey J.B., Posternak M.A., Friedman M., Attiullah N., and Boerescu D. How should remission from depression be defined? The depressed patient's perspective. American Journal of Psychiatry 163 (2006) 148-150